|
KMID : 1143920200240020216
|
|
Annals of Hepato-Biliary-Pancreatic Surgery
2020 Volume.24 No. 2 p.216 ~ p.220
|
|
|
Effect of everolimus rescue therapy for acute cellular rejection following pediatric living donor liver transplantation: Report of one case
|
|
Hwang Shin
Namgoong Jung-Man
Oh Seak-Hee
Kim Kyung-Mo
Ahn Chul-Soo
Kwon Hyun-Hee
Cho Yu-Jeong
Kwon Yong-Jae
|
|
|
Abstract
|
|
|
|
Acute cellular rejection (ACR) after pediatric living donor liver transplantation (LDLT) is often curable with steroid pulse therapy, but a few pediatric patients show steroid-resistant ACR, which is difficult to control. We report the effect of everolimus as a rescue therapy for ACR in a case of pediatric LDLT. The patient was a 11-year-old girl who was admitted due to subacute liver failure of unknown cause. LDLT operation using a modified right liver graft from her mother was performed. The graft-recipient weight ratio was 1.30. The explant liver showed massive hepatic necrosis. The patient recovered uneventfully with immunosuppression using tacrolimus and low-dose steroid. However, at postoperative day (POD) 20, the liver enzyme levels began to increase. The first liver biopsy taken at POD 25 showed moderate ACR with rejection activity index (RAI) score of 7. At that time, steroid pulse therapy was performed, but the patient did not respond and the liver enzyme levels increased further. The second liver biopsy taken at POD 40 showed moderate ACR with RAI score of 7. At this time, everolimus was administered, and soon after that, liver enzyme levels had gradually improved. Currently, the patient is doing well for 44 months to date without any abnormal findings. The maintenance target trough concentrations were tacrolimus 5 ng/ml and everolimus 3 ng/ml. Our case demonstrated the effect of rescue therapy using everolimus for ACR following pediatric LDLT. Further studies are needed to assess the role of everolimus in pediatric liver transplant recipients suffering from ACR.
|
|
|
KEYWORD
|
|
|
Acute cellular rejection, Rescue therapy, Immunosuppression, Everolimus, Sirolimus
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
 
|
|